BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Publication » Autonomic innervation of beta-cells in InSight

Autonomic innervation of beta-cells in InSight

Blood glucose levels are controlled by the autonomous nervous system. Parasympathetic axons directly influence islet function, leading to higher insulin release and lower levels of blood glucose. The results are published in December 2012 in PNAS.

The autonomous nervous system responsible for the unconscious regulation consists of parasympathetic and sympathetic parts, managing the calm and stressful conditions respectively. The scientific community has under many years speculated that the autonomous nervous system controls levels of blood glucose:

  • To prepare for flight, the sympathetic nervous system is anticipated to lower levels of insulin production and leave more glucose in the blood to provide more energy for the body.
  • During a relaxed period, the parasympathetic system stimulates islets to produce more insulin and reduce the levels of glucose.

Recently, researchers in PO Berggren’s group in Miami have for the first time proven that autonomic nerves influence blood sugar levels.

To study the direct interaction between the axons and the insulin-producing beta cells, the researchers transplanted islets into the anterior chamber of the mouse eye using the InSight Technology. The islets became fully innervated by axons in a manner similar to that in the pancreas.

The researchers then exposed the mice to light and darkness to stimulate the parasympathetic and sympathetic nervous system respectively. The pupil contracts on exposure to light, sending a signal to the parasympathetic system. In contrast, when in darkness, the pupil opens, signalling to the sympathetic system.

The experiments showed the following:

  • When mice were in bright light, transplanted islets released more insulin, lowering the levels of blood sugar. This effect was inhibited by blocking the parasympathetic pathway with a drug applied as an eye drop.
  • When the animals were put into darkness, the islets released less insulin, resulting in higher blood glucose levels.
  • There is a connection between the density of innervation and how levels of glucose are controlled: The stronger the innervation, the better it compensates for increased insulin demands.

These findings are fundamental for understanding the dependency of insulin secretion on the autonomous nervous system. In the longer run, they may explain the development and progress of diabetes and potentially new ways to treat the disease.

The results are published in December 2012: Non-invasive in vivo model demonstrating the effects of autonomic innervation on pancreatic islet function.  Rayner Rodriguez-Diaz, Stephan Speier, Ruth Damaris Molano, Alexander Formoso, Itai Gans, Midhat H. Abdulreda, Over Cabrera, Judith Molina, Alberto Fachado, Camillo Ricordi, Ingo Leibiger, Antonello Pileggi, Per-Olof Berggren and Alejandro Caicedo. Proceedings of the National Academy of Sciences (PNAS). Online Early Edition 10-14 December 2012

December 27, 2012 Catharina Rahm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications February 6, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved